Cryomass Technologies Inc

Company Profile

Cryomass Technologies Inc had its IPO on under the ticker symbol CRYM.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Cryomass Technologies Inc has a staff strength of 0 employees.

Stock update

Shares of Cryomass Technologies Inc opened at $0.1 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.1 - $0.1, and closed at $0.1.

This is a +4.38% increase from the previous day's closing price.

A total volume of 29,723 shares were traded at the close of the day’s session.

In the last one week, shares of Cryomass Technologies Inc have increased by +7.07%.

Cryomass Technologies Inc's Key Ratios

Cryomass Technologies Inc has a market cap of $24.23 million, indicating a price to book ratio of 4.4359 and a price to sales ratio of 0.

In the last 12-months Cryomass Technologies Inc’s revenue was $0 with a gross profit of $37176 and an EBITDA of $-9455877. The EBITDA ratio measures Cryomass Technologies Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Cryomass Technologies Inc’s operating margin was 0% while its return on assets stood at -60.99% with a return of equity of -132.4%.

In Q1, Cryomass Technologies Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Cryomass Technologies Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.06 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cryomass Technologies Inc’s profitability.

Cryomass Technologies Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -6.1161. Its price to sales ratio in the trailing 12-months stood at 0.

Cryomass Technologies Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$6.59 million

Total Liabilities

$1.43 million

Operating Cash Flow

$0

Capital Expenditure

$13736

Dividend Payout Ratio

0%

Cryomass Technologies Inc ended 2024 with $6.59 million in total assets and $0 in total liabilities. Its intangible assets were valued at $6.59 million while shareholder equity stood at $3.15 million.

Cryomass Technologies Inc ended 2024 with $0 in deferred long-term liabilities, $1.43 million in other current liabilities, in common stock, $-40610054.00 in retained earnings and $1.19 million in goodwill. Its cash balance stood at $663978.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $2.00 million.

Cryomass Technologies Inc’s total current assets stands at $778540.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $0 and inventory worth $0.

In 2024, Cryomass Technologies Inc's operating cash flow was $0 while its capital expenditure stood at $13736.

Comparatively, Cryomass Technologies Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.1

52-Week High

$0.378

52-Week Low

$0.081

Analyst Target Price

$

Cryomass Technologies Inc stock is currently trading at $0.1 per share. It touched a 52-week high of $0.378 and a 52-week low of $0.378. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.13 and 200-day moving average was $0.14 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 2562% of the company’s stock are held by insiders while 0% are held by institutions.